Key result
Captopril improved heart failure control in infants with a left-to-right shunt, increasing mean weight gain from 48 to 102 g/week and decreasing mean respiratory rate from 68 to 60 breaths/minute.
Why the study?
Does captopril improve heart failure control in infants with left-to-right shunts poorly controlled by digoxin and diuretics?
Observational (n=20)
Does captopril improve heart failure control in infants with left-to-right shunts poorly controlled by digoxin and diuretics?
Absolute Event Rate: 102% vs 48%
Captopril improves clinical signs of heart failure (weight gain and respiratory rate) in infants with left-to-right shunts, though it carries risks of hypotension and renal impairment.
May support adjunctive use in refractory cases; leaves open randomized confirmation of benefit and safety.
Captopril was used in 20 infants aged less than 1 year with heart failure secondary to defects with predominantly a left to right shunt that was poorly controlled with digoxin and diuretics. Total daily dose of captopril ranged from 0.88 to 2.5 mg/kg (mean 1.3 mg/kg) in three divided doses. Improvement in the control of heart failure was seen mainly as an increase in the rate of weight gain from a mean of 48 g/week before treatment to 102 g/week on treatment and a decrease in the mean respiratory rate from 68 breaths/minute to 60 breaths/minute. Side effects were seen in four patients--two with asymptomatic mild hypotension, one with renal insufficiency which improved with a reduction in dose, and one with severe oliguria progressing to renal failure. Significant changes in plasma electrolyte concentration did not occur except in the infant who developed acute renal failure.
No takes yet. Share an insight, caveat, or question.
Shaw et al. (1988) conducted an observational in Heart failure secondary to a left to right shunt (n=20). Captopril vs. Before treatment was evaluated on Rate of weight gain (g/week). Captopril improved heart failure control in infants with a left-to-right shunt, increasing mean weight gain from 48 to 102 g/week and decreasing mean respiratory rate from 68 to 60 breaths/minute.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: